260 results
8-K
EX-99.1
CDXC
Chromadex Corp
6 Mar 24
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results
4:02pm
.
In November 2023, clinical trial published in the peer-reviewed journal, Nature Communications, found that high-dosages of Niagen® induces a potent NAD … to revenue growth, gross margin, expenses, and investment plans.
Risks that contribute to the uncertain nature of the forward-looking statements
8-K
EX-99.1
CDXC
Chromadex Corp
10 May 23
ChromaDex Corporation Reports First Quarter 2023 Financial Results
4:02pm
plans. Risks that contribute to the uncertain nature of the forward-looking statements include: inflationary conditions and adverse economic conditions … of the non-GAAP financial measure has substance because the excluded expenses are infrequent in nature, are variable in nature or do not represent
8-K
EX-99.1
CDXC
Chromadex Corp
8 May 24
ChromaDex Corporation Reports First Quarter 2024 Financial Results
4:02pm
outlook including but not limited to revenue growth, gross margin, expenses, and investment plans. Risks that contribute to the uncertain nature … substance because the excluded expenses are infrequent in nature, are variable in nature or do not represent current cash expenditures. Further
8-K
EX-99.1
CDXC
Chromadex Corp
10 Aug 22
ChromaDex Corporation Reports Second Quarter 2022 Financial Results
4:06pm
, gross margin, expenses, and investment plans. Risks that contribute to the uncertain nature of the forward-looking statements include: the impact … are infrequent in nature, are variable in nature or do not represent current cash expenditures. Further, these non-GAAP financial measures are among
8-K
EX-99.1
h5bsf m6i
8 Nov 23
ChromaDex Corporation Reports Third Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
e6sb yp69
9 Aug 23
ChromaDex Corporation Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
8evt b9kecfp
12 May 22
ChromaDex Corporation Reports First Quarter 2022 Financial Results
4:03pm
8-K
EX-99.1
14rkj9aim1j1ijg
2 Nov 22
ChromaDex Corporation Reports Third Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
py9i5dmkm3e8gd3ajb8
9 Mar 22
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2021 Results
4:01pm
8-K
EX-99.1
zcxnv
3 Nov 21
ChromaDex Corporation Reports Third Quarter 2021 Financial Results
4:04pm
8-K
EX-99.1
pqxon8em 7u
3 Aug 21
ChromaDex Corporation Reports Second Quarter 2021 Financial Results
4:37pm
8-K
EX-10.1
2m1cnsu4
12 Jun 12
ChromaDex® Corp. Names Co-founder Frank Jaksch CEO & President
12:00am